ADAPTIVE
Adaptive Biotechnologies Corporation
Application Filed: 2018-04-16
Trademark Application Details
OPPOSITION PENDING
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87878532 |
| Registration Number | 6866517 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Hoang-chi Truong |
| Law Office Assigned | L40 |
| Employee Name | CHADAB, SETH WILLIG |
Timeline
| 2018-04-16 | Application Filed |
| 2018-11-13 | Published for Opposition |
| 2018-11-19 | Status: Live/Pending |
| 2019-09-27 | Location: TMO LAW OFFICE 100 - EXAMINING ATTORNEY ASSIGNED |
| 2019-09-27 | Transaction Date |
| 2022-10-04 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Adaptive Biotechnologies Corporation |
| Address | 1551 Eastlake Avenue E, Suite 200 Seattle WA 98102 |
| Legal Entity Type | Corporation |
| Legal Entity State | WA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy |
| GS0441 | Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-04-19 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-04-24 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-08-03 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-08-08 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2018-08-08 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-08-08 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-09-17 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-09-17 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-09-18 | 9 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-09-20 | 10 CNSA P: |
| ASSIGNED TO LIE | 2018-10-05 | 11 ALIE A:Allowance for Publication |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-10-24 | 12 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-11-13 | 13 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-11-13 | 14 NPUB E:E-Mail |
| OPPOSITION PAPERS RECEIVED AT TTAB | 2018-11-19 | 15 OPPF T:TTAB Proceeding |
| OPPOSITION INSTITUTED NO. 999999 | 2018-11-19 | 16 OP.I T:TTAB Proceeding |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-04-16 | 17 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-04-16 | 18 ARAA I:Incoming Correspondence |
| TEAS PETITION TO DIRECTOR RECEIVED | 2019-04-17 | 19 TPDR I:Incoming Correspondence |
| ASSIGNED TO PETITION STAFF | 2019-05-24 | 20 APET A:Allowance for Publication |
| ASSIGNED TO PETITION STAFF | 2019-06-20 | 21 APET A:Allowance for Publication |
| ASSIGNED TO PETITION STAFF | 2019-08-19 | 22 APET A:Allowance for Publication |
| PETITION TO DIRECTOR DENIED | 2019-09-27 | 23 PCDE O:Outgoing Correspondence |
| OPPOSITION DISMISSED NO. 999999 | 2020-07-07 | 24 OP.D T:TTAB Proceeding |
| OPPOSITION TERMINATED NO. 999999 | 2020-07-07 | 25 OP.T T:TTAB Proceeding |
| TTAB RELEASE CASE TO TRADEMARKS | 2020-07-07 | 26 TMBN T:TTAB Proceeding |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-07-08 | 27 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-07-08 | 28 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-07-08 | 29 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-07-08 | 30 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-07-08 | 31 CHAN I:Incoming Correspondence |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-08-18 | 32 NOAM E:E-Mail |
| NOTICE OF ALLOWANCE CANCELLED | 2020-12-10 | 33 IUCN S: |
| CASE ASSIGNED TO TTAB | 2020-12-10 | 34 TTBN I:Incoming Correspondence |
| OPPOSITION DISMISSED NO. 999999 | 2021-12-07 | 35 OP.D T:TTAB Proceeding |
| TTAB RELEASE CASE TO TRADEMARKS | 2021-12-07 | 36 TMBN T:TTAB Proceeding |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-01-18 | 37 NOAM E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2022-07-15 | 38 EISU I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2022-07-15 | 39 EEXT I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-07-15 | 40 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-07-15 | 41 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-07-15 | 42 TCCA I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-08-01 | 43 AITU A:Allowance for Publication |
| USE AMENDMENT FILED | 2022-07-15 | 44 IUAF S: |
| SOU EXTENSION 1 FILED | 2022-07-15 | 45 EXT1 S: |
| SOU EXTENSION 1 GRANTED | 2022-08-05 | 46 EX1G S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2022-08-05 | 47 SUPC I:Incoming Correspondence |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-08-06 | 48 EXRA E:E-Mail |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2022-08-29 | 49 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2022-08-30 | 50 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2022-10-04 | 51 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-10-04 | 52 NRCC E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 